Echo Healthcare Acquisition Corp. - Management & Board of Directors

Management & Board of Directors

Gene Burleson (Chairman, Chief Executive Officer)

Over 24 years of experience in the healthcare industry;
President and Chief Operating Officer and member of the board of directors of American Medical International, Inc. (formerly listed on NYSE), or AMI, formerly one of the leading hospital management companies in the United States, from 1986 to 1989. Prior to serving as President of AMI, Mr. Burleson was President and Chief Executive Officer of American Medical International-European Operations for nine years. Mr. Burleson began his employment with AMI in 1974;
Chairman of the board of directors of GranCare, Inc. (formerly listed on NYSE), an operator of long-term care facilities and pharmacy operations, from 1989 to 1997 and President and Chief Executive Officer of GranCare from 1990 to 1997. Mr. Burleson helped to increase GranCare's revenue from $18.5 million in 1989 to over $1 billion in 1996;
From February 1997 to August 1997, Chief Executive Officer and member of the board of directors of Vitalink Pharmacy Services, Inc. (formerly listed on NYSE) after its merger with the pharmacy operations of GranCare;
In 2000, formed the blank check acquisition company, Sovereign Medical Acquisition Co., raising $9 million from private investors, and acquired HealthMont Inc., an operator of community hospitals, which was subsequently acquired by SunLink Health Systems, Inc. (AMEX:SSY), an owner and operator of acute care hospitals;
Member of the board of directors of SunLink Health Systems, Inc. since 2003 and a member of the board of directors of HealthMont Inc. from 2000 until its acquisition by SunLink Health Systems, Inc. in 2003;
Chairman of the board of directors of Mariner Post-Acute Network, Inc., an operator of long-term care facilities, from 2000 to 2002;
Chairman of the board of directors of Alterra Healthcare Corporation (formerly listed on AMEX), a developer and operator of assisted living facilities during 2003;
Member of the board of directors of Prospect Medical Holdings, Inc. (AMEX:PZZ), a provider of management services to affiliated independent physician associations, since 2004;
Member of the board of directors of Nesco Industries, Inc. (OTCBB:NESK.OB), a manufacturer of aqueous polymer Hydrogel used for wound care and transdermal drug delivery systems, since 2004;
Member of the board of directors of BioHorizons Implant Systems, Inc., a provider of dental implants and related products, since 1998;
Member of the board of directors Med Images, Inc., a provider of integrated documentation services to surgeons and hospitals through multimedia technology, since 1998;
Member of the board of directors Marina Medical, Inc., a provider of medical billing and accounts receivable management services to hospital based physicians, since 1999;
Member of the board of directors Footcare Associates, Inc., a provider of therapeutic and diabetic footwear, since 2004; and
Member of the board of directors of David Braun Productions, Inc., a provider of children's television programs, since 2003.

Joel Kanter (President, Secretary, Director)

Over 18 years experience in the healthcare industry;
Chief Executive Officer and President, from 1995 to 1999, of Walnut Financial Services, Inc. (formerly listed on the Nasdaq), a provider of equity financing to start-up and early stage development companies, bridge financing and factoring services to small and medium-sized companies, and later stage institutional financing to more mature enterprises. Ventures financed through Walnut Financial Services, Inc. include Plax Mouthwash (Oral Research Laboratories), Sonicare Toothbrushes (Optiva Corp.), the first manufacturer of Global Positioning System devices (Magellan Corp.), the largest and only nationwide Preferred Provider Organization (First Health), one of the country's largest nursing home companies (GranCare), and one of the country's largest institutional pharmacy companies (Vitalink Pharmacy Services, Inc.);
In 2000, formed the blank check acquisition company, Sovereign Medical Acquisition Co., raising $9 million from private investors, and acquired HealthMont Inc., an operator of community hospitals, which was subsequently acquired by SunLink Health Systems, Inc.;
In 1995, Mr. Kanter, formed an acquisition company named Healthcare Acquisition Corp. and raised approximately $10.3 million from public investors. In 1997, it acquired, through a reverse merger, Encore Medical Corporation (Nasdaq:ENMC), a broad based orthopedics products company involved in developing, manufacturing, marketing and distributing high quality medical goods and services throughout the world;
Member of the board of directors of Encore Medical Corporation from 1997 to November 2006 when the company was sold to the Blackstone Group;
Member of the board of directors of I-Flow Corporation (Nasdaq:IFLO), a company that designs, develops, manufactures and markets technically advanced, low-cost ambulatory drug delivery systems to provide life enhancing, cost effective solutions for pain management and infusion therapy for use in hospitals and other settings, including free-standing surgery centers and physicians' offices, since 1991;
Member of the board of directors of Logic Devices, Inc. (Nasdaq:LOGC), a company that develops and markets high-performance digital integrated circuits that address the requirements of original equipment manufacturers to provide high-speed electronic computation and storage in digital signal processing, video image processing, and telecommunications applications, since 2002;
Member of the board of directors of Magna-Lab, Inc. (OTCBB:MAGLA.OB, formerly listed on Nasdaq), a company that had been focused on the pre-revenue development and commercialization of disposable medical devices designed to enhance the effectiveness of magnetic resonance imaging in detection and diagnosis of heart disease, since 1998;
Member of the board of directors of Prospect Medical Holdings, Inc. (AMEX:PZZ), a provider of management services to affiliated independent physician associations, since 2004;
Member of the board of directors of Nesco Industries, Inc. (OTCBB:NESK.OB), a manufacturer of aqueous polymer Hydrogel used for wound care and transdermal drug delivery systems, since 2004;
Member of the board of directors BioHorizons Implant Systems, Inc., a provider of dental implants and related products, since 2002;
Member of the board of directors Med Images, Inc., a provider of integrated documentation services to surgeons and hospitals through multimedia technology, since 1990;
Member of the board of directors Marina Medical, Inc., a provider of medical billing and accounts receivable management services to hospital based physicians, since 1999;
Member of the board of directors of David Braun Productions, Inc., a provider of children's television programs, since 1998;
President of Windy City, Inc., a privately held investment firm, since 1986; and
Managing Director of The Investors' Washington Service, an investment advisory firm specializing in providing advice to large institutional clients regarding the impact of federal legislative and regulatory decisions on debt and equity markets, from its formation in 1985 to its sale in 1986 to Government Consulting Company.

Kevin Pendergest (Chief Financial Officer, Treasurer, Director)

Eugene A. Bauer, M.D. (Director)

Gary A. Brukardt (Director)

Alastair Clemow, PhD (Director)

Over 28 years experience in the healthcare industry;
President and Chief Executive Officer of Nexgen Spine Inc., a private company developing an artificial spinal implant, since 2004;
President and Chief Executive Officer of Gelifex, Inc., a medical device company developing an innovative spinal nucleus replacement implant, from its founding in 2002 to its sale in 2004 to Synthes Spine;
President and Chief Executive Officer of Minimally Invasive Surgical Technologies, a start-up company developing procedures and implants for minimally invasive total knee replacement, from its founding in 2001 until its merger with Z-Kat in 2004;
Founder and Principal of Tanton Technologies, an organization that provides strategic and technical assessment of new medical device opportunities for large, mid-cap and early stage development companies, from 2000 to 2004;
Various positions with Johnson & Johnson (NYSE:JNJ), including Vice President of Worldwide Business Development for Ethicon Endo-Surgery Inc., Vice President of New Business Development for Johnson & Johnson Professional Inc., and Director of Research and Development of Johnson & Johnson Orthopedics from 1981 to 2000;
Member of the board of directors of Encore Medical Corporation (Nasdaq:ENMC), a diversified orthopedic company that manufactures and distributes a comprehensive range of high quality orthopedic devices, including surgical implants, sports medicine equipment and products for orthopedic rehabilitative pain management and physical therapy, from 2003 to November 2006 when the company was sold to the Blackstone Group;
Member of the board of directors of HydroCision Inc., a manufacturer and developer of surgical instruments for both orthopedic and general surgery procedures, since 2004;
Member of board of directors of BioMedical Enterprises Inc., a manufacturer and developer of orthopedic implants, since 2000; and
President of the Society for Biomaterials in 1995.

Richard O. Martin, PhD (Director)

Over 30 years experience in the healthcare industry;
President of Medtronic Physio-Control Corp. (NYSE:MDT), successor company to Physio-Control International Corporation from 1998 to 2001;
Chairman and CEO of Physio-Control International Corporation, the worldwide leader in external defibrillation, monitoring and noninvasive pacing systems from 1991 to 1998. Company went public in 1995 on the Nasdaq National Market raising approximately $194.6 million;
Vice President of Cardiovascular Business Development of Sulzermedica, Inc., successor company to Intermedics, Inc. during 1989 and 1990;
Various positions with Intermedics, Inc., a company specializing in the development, manufacturing and marketing of implantable products. Primary products included cardiac pacemakers, intraocular lenses, orthopedic implants and heart valves from 1978 to 1989. Served as a director and President and Chief Operating Officer of Intermedics, Inc. from 1985 to 1988;
Director, President and Chief Operating Officer of Positron Corporation (OTCBB:POSC), a company that designs, manufactures, markets and services advanced medical imaging devices utilizing positron emission tomography, or PET, technology under the trade-name POSICAM™ systems, during 1989 and 1990;
Director of Clinical Engineering and Advanced Lead design for Medtronic, Inc. from 1975 to 1978;
Chairman of the board of directors of the Northwest affiliate of the American Heart Association from 1997 to 1999;
Chairman of the board of directors of the Medical Device Manufacturers Association from 1996 to 1998;
Director of the Washington Council of AeA (formerly the American Electronics Association) from 1991 to 2001 and served as the National Chairman of AeA during 2000 through 2001;
Member of the board of directors of CardioDynamics International Corporation (Nasdaq:CDIC), a company that develops, manufactures and markets noninvasive impedance cardiography diagnostic and monitoring technologies and electrocardiograph electrode sensors, since July 1997;
Member of the board of directors of Encore Medical Corporation (Nasdaq:ENMC), a broad based orthopedics products company involved in developing, manufacturing, marketing and distributing high quality medical goods and services throughout the world, from 1996 to November 2006 when the company was sold to the Blackstone Group;
Member of the board of directors of Inovise Medical Inc., a company that develops and markets advanced electrocardiographic, or ECG, systems utilizing both 12-lead ECG and mechanical heart sounds, since 2001;
Member of the board of directors of Cardiac Dimensions, Inc., an early stage company developing minimally invasive tools for mitral valve repair, since 2003;
Member of the board of directors of EsophyX, Inc., an early stage company developing innovative, minimally invasive devices for the treatment of gastroesophageal reflux disease, since 2003; and
Member of the board of directors of MDdatacor, a company developing medical data mining software, since 2004.